Preanalytical factors affecting RIA measurement of plasma kisspeptin.
Ramachandran R, Patterson M, Murphy KG, Dhillo WS, Patel S, Kazarian A, Ghatei MA, Bloom SR
Purpose
Conclusion
Studies (3)
Purpose
This study examined the stability of kisspeptin immunoreactivity (IR) in serum specimens subjected to a preprocessing room temperature delay of 0-4 h. Kisspeptin IR levels in serum and immediately processed plasma specimens were also compared. Biospecimens were collected from healthy pregnant women for all studies.
Summary of Findings
In serum specimens, detectable kisspeptin IR was limited to samples processed immediately (0 h). Kisspeptin IR levels were significantly lower in immediately processed serum specimens compared to corresponding plasma specimens.
Biospecimens
FluidSerumFluidPlasmaFluidBloodPreservation Types
FrozenDiagnoses
PregnantPlatforms
PeptideRadioimmunoassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Blood and blood products PlasmaSerumBiospecimen Aliquots and Components Centrifugation Centrifugation delays investigatedStorage Time at room temperature 0 h1 h2 h4 h
Purpose
The purpose of this study was to investigate whether a preprocessing room temperature delay and the type of anticoagulant used impacts plasma kisspeptin immunoreactivity (IR), as determined by radioimmunoassay. Biospecimens were collected from healthy pregnant women.
Summary of Findings
Although not significant, plasma kisspeptin IR was lower in specimens treated with citrate compared to EDTA or lithium heparin. IR was inversely proportional to the duration of a pre-processing delay at room temperature, with a significant decrease (compared to 0 h controls) after 1 or 2 h in SST or citrate and lithium heparin treated specimens, respectively. Plasma specimens treated with EDTA were stable at room temperature for up to 4 h.
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
FrozenDiagnoses
PregnantPlatforms
PeptideRadioimmunoassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant CitrateEDTALithium heparinNoneBiospecimen Acquisition Type of collection container/solution Serum clot activator (S)Serum separator (SST)Biospecimen Aliquots and Components Blood and blood products PlasmaSerumBiospecimen Aliquots and Components Centrifugation Centrifugation delays investigatedStorage Time at room temperature 0 h1 h2 h4 h
Purpose
The purpose of this study was to determine if multiple freeze-thaw cycles impact kisspeptin immunoreactivity (IR) in EDTA or lithium heparin treated plasma specimens. Biospecimens were collected from healthy pregnant women, and samples were processed immediately.
Summary of Findings
Although data was not shown, the authors report freeze-thaw cycling up to 4 times, did not significantly affect kisspeptin IR in plasma treated with EDTA or lithium heparin.
Biospecimens
FluidPlasmaFluidBloodPreservation Types
FrozenDiagnoses
PregnantPlatforms
PeptideRadioimmunoassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant EDTALithium heparinStorage Freeze/thaw cycling 0 cycles1 cycle2 cycles3 cycles4 cycles